|

Prospective Registry of Histotripsy for Soft Tissue Tumors

RECRUITINGSponsored by University of California, San Francisco
Actively Recruiting
SponsorUniversity of California, San Francisco
Started2026-01-29
Est. completion2030-08-08
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07470008

Summary

Histotripsy is a treatment that uses focused ultrasound waves to break down tissue without surgery. The ultrasound waves meet at a specific spot and turn the tissue into liquid. This study is a prospective observational registry of participants receiving histotripsy. The goal of this study is to gather information about the use of histotripsy to confirm it is safe and effective medical procedure.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* All adult patients who are treated with histotripsy per standard clinical care at University of California San Francisco (UCSF) are eligible for inclusion in the registry.

Exclusion Criteria:

* Children/minors, and adults who lack decision-making capacity, will be excluded from the registry. Patients who do not consent for inclusion in the registry will also be excluded.

Conditions4

CancerSoft Tissue CancerSoft Tissue LesionSoft Tissue Neoplasm

Locations1 site

University of California, San Francisco
San Francisco, California, 94143
Ryan Lokken, MD877-827-3222cancertrials@ucsf.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.